Form 4: ClearPoint Neuro Director Linda M. Liau Acquires Shares in Lieu of Fees
SEC Form 4
Director Linda M. Liau acquired 264 shares of ClearPoint Neuro, Inc. common stock on October 1, 2024, in lieu of fees owed under the company's Non-Employee Director Compensation Plan.
Summary
- On October 1, 2024, Linda M. Liau, a director of ClearPoint Neuro, Inc., acquired 264 shares of common stock.
- The shares were issued as payment for fees owed to Liau under the company's Non-Employee Director Compensation Plan.
- The price per share was $11.21, based on the closing price of ClearPoint Neuro's common stock on September 30, 2024.
- Following the transaction, Liau directly owns 31,098 shares of ClearPoint Neuro, Inc.
Sentiment
Score: 6
Explanation: The document reflects a routine transaction. The sentiment is neutral as it is a standard compensation practice.
Positives
- The acquisition of shares by a director demonstrates confidence in the company.
Industry Context
Directors receiving stock in lieu of cash compensation is a common practice, particularly for smaller companies, to conserve cash and align director interests with shareholder value.
Related Party Transactions
- The issuance of shares to Linda M. Liau, a director, in lieu of fees is a related party transaction.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it involves a small number of shares.
Key Dates
| Date | Description |
|---|---|
| 09/30/2024 | Closing price of ClearPoint Neuro's common stock used to determine the share price for the transaction. |
| 10/01/2024 | Date of the transaction where Linda M. Liau acquired 264 shares of ClearPoint Neuro, Inc. |
| 10/02/2024 | Date of signature on the SEC Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.